Mark Altmeyer

Mark Altmeyer

Directeur/Membre du Conseil chez ALECTOR, INC.

Fortune : 213 084 $ au 31/05/2026

65 ans
Health Technology
Commercial Services
Consumer Services

Profil

Mr. Mark F.
Altmeyer
is a Chairman at Calluna Pharma, Inc., an Independent Director at Alector, Inc., a Chairman-Supervisory Board at AM-Pharma BV and a Chief Executive Officer & Director at Arvelle Therapeutics International GmbH.
He is on the Board of Directors at Aculys Pharma LLC, Alector, Inc., Novaremed AG, Arvelle Therapeutics International GmbH and Contact of Mercer County.
Mr. Altmeyer was previously employed as an Independent Director by Clarion Healthcare LLC, a Chief Executive Officer & Executive Director by Arvelle Therapeutics BV, a President & Chief Commercial Officer by Axovant Sciences GmbH, an Independent Director by Myovant Sciences Ltd., a President & Chief Commercial Officer by Axovant Sciences, Inc., a President & Chief Commercial Officer by Axovant Gene Therapies Ltd., a President & Chief Executive Officer by Otsuka America Pharmaceutical, Inc., and a Senior Vice President by Bristol Myers Squibb Co. He also served on the board at Roivant Sciences GmbH.
He received his undergraduate degree from Middlebury College and an MBA from Harvard Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
17/06/2026 98 650 ( 0,09% ) 213 084 $ 31/05/2026

Postes actifs de Mark Altmeyer

SociétésPosteDébut
ALECTOR, INC. Directeur/Membre du Conseil 19/03/2024
Directeur/Membre du Conseil 01/12/2021
Président 06/07/2021
Fondateur 01/01/2019
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/04/2024

Anciens postes connus de Mark Altmeyer

SociétésPosteFin
Independent Dir/Board Member 01/10/2022
Fondateur 01/02/2021
SIO GENE THERAPIES INC. President 15/02/2019
░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ -
░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Mark Altmeyer

Formation de Mark Altmeyer

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

60

Relations au 1er degré

17

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées17

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. Mark Altmeyer